Active Ingredient History

  • Now
Inamrinone (Amrinone) is a positive inotropic cardiotonic with vasodilator properties, phosphodiesterase inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell. Inamrinone is a phosphodiesterase inhibitor (PDE3), resulting in increased cAMP and cGMP which leads to an increase in the calcium influx like that caused by beta-agonists resulting in increased inotropic effect. Inamrinone is used in the treatment of congestive heart failure.   NCATS

  • SMILES: NC1=CC(=CNC1=O)c2ccncc2
  • Mol. Mass: 187.2
  • ALogP: 1.02
  • ChEMBL Molecules:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No
amcoral | amrinona | amrinone | amrinone lactate | amrinonum | cartonic | cordemcura | inamrinone | inamrinone lactate | inocor | vesistol | win-40680 | wincoram


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue